{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:55:44Z","timestamp":1792166144853,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.acuroe.2026.502000","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:09:11Z","timestamp":1783469351000},"page":"502000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of mirabegron for the treatment of bladder dysfunction in the pediatric population: A prospective observational study"],"prefix":"10.1016","volume":"50","author":[{"given":"L.E.","family":"Zelaya-Contreras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ruiz-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Vargas Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Paredes Esteb\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Parente Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2026.502000_bib0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0090-4295(83)90079-1","article-title":"Estimating bladder capacity in children","volume":"21","author":"Koff","year":"1983","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2026.502000_bib0010","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.juro.2014.01.110","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents","volume":"191","author":"Austin","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2026.502000_bib0015","article-title":"EAU guidelines on paediatric urology","author":"Tekg\u00fcl","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.502000_bib0020","first-page":"441","article-title":"Management and treatment of nocturnal enuresis","volume":"183","author":"Nev\u00e9us","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2026.502000_bib0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","article-title":"Antimuscarinics in overactive bladder: clinical efficacy and tolerability","volume":"54","author":"Chapple","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.502000_bib0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41598-020-80211-6","article-title":"The effects of anticholinergic medications on cognition in children: a systematic review and meta-analysis","volume":"11","author":"Ghezzi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.acuroe.2026.502000_bib0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-5347(06)00301-6","article-title":"Botulinum toxin a in children with therapy-resistant detrusor overactivity","volume":"176","author":"Hoebeke","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2026.502000_bib0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0302-2838(01)00009-4","article-title":"Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review","volume":"41","author":"Rovner","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.502000_bib0045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/nau.20420","article-title":"Beta3-adrenoceptors in urinary bladder","volume":"26","author":"Yamaguchi","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuroe.2026.502000_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/nau.22505","article-title":"Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability","volume":"33","author":"Chapple","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuroe.2026.502000_bib0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eururo.2016.02.007","article-title":"Prospective pilot study of mirabegron in pediatric patients with overactive bladder","volume":"70","author":"Blais","year":"2016","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.acuroe.2026.502000_bib0060","first-page":"1900","article-title":"Efficacy and safety of mirabegron in pediatric neurogenic detrusor overactivity","volume":"40","author":"Baka-Ostrowska","year":"2021","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.acuroe.2026.502000_bib0065","doi-asserted-by":"crossref","first-page":"31.e1","DOI":"10.1016\/j.jpurol.2019.10.009","article-title":"Pharmacokinetics, safety, and tolerability of mirabegron in children and adolescents with neurogenic detrusor overactivity or idiopathic overactive bladder","volume":"16","author":"Rittig","year":"2020","journal-title":"J Pediatr Urol"},{"issue":"5","key":"10.1016\/j.acuroe.2026.502000_bib0070","article-title":"Long-term effects of mirabegron in pediatric neurogenic lower urinary tract dysfunction","volume":"19","author":"van Veen","year":"2023","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.acuroe.2026.502000_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpurol.2024.12.003","article-title":"Long-term outcomes of mirabegron combined therapy in children with neurogenic bladder","author":"Taghizadeh","year":"2025","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.acuroe.2026.502000_bib0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpedsurg.2019.10.044","article-title":"Effectiveness and tolerability of mirabegron in children with overactive bladder: a retrospective pilot study","volume":"55","author":"Fryer","year":"2020","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.acuroe.2026.502000_bib0085","series-title":"Proceedings of the 28th ESPU congress","article-title":"Urodynamic efficacy of mirabegron in pediatric patients with spina bifida","author":"Lee","year":"2017"},{"key":"10.1016\/j.acuroe.2026.502000_bib0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(10)62226-X","article-title":"Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age","volume":"377","author":"Fleming","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.acuroe.2026.502000_bib0095","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.acuroe.2026.502000_bib0100","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jcph.1107","article-title":"Cardiovascular safety of the \u03b23-adrenoceptor agonist mirabegron and solifenacin in the SYNERGY trial","volume":"58","author":"White","year":"2018","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.acuroe.2026.502000_bib0105","first-page":"781","article-title":"Relationship between overactive bladder and dysfunctional voiding in children","volume":"29","author":"Kim","year":"2022","journal-title":"Int J Urol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626001459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626001459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:32:00Z","timestamp":1792164720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578626001459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2173578626001459"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.502000","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of mirabegron for the treatment of bladder dysfunction in the pediatric population: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.502000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2026.502000","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502000"}}